Peregrine soars as cancer drug meets trial goal
(Reuters) - Peregrine Pharmaceuticals Inc said results from a mid-stage trial showed that its key experimental drug performed better than standard chemotherapy in lung cancer patients who had not responded to primary therapy, sending its shares up 36 percent. (Source: Reuters: Health)div id=medwormpbiMedWorm Sponsor Message:/i/b Have a look at a href=http://www.thepsychologydaily.comThe Psychology Daily/a, the new psychology portal powered by MedWorm, with all the latest psychology news and research updated daily./p/div

NHS trust fined for data breach
An NHS trust is fined £90,000 after details of 59 patients were mistakenly sent to a member of the public. (Source: BBC News | Health | UK Edition)